307 related articles for article (PubMed ID: 20367669)
21. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
Richter JR; Förström LR; Kiistala UO; Jung EG
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
[TBL] [Abstract][Full Text] [Related]
22. The efficacy of topical cyproterone acetate alcohol lotion versus placebo in the treatment of the mild to moderate acne vulgaris: a double blind study.
Iraji F; Momeni A; Naji SM; Siadat AH
Dermatol Online J; 2006 Mar; 12(3):26. PubMed ID: 16638440
[TBL] [Abstract][Full Text] [Related]
23. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
24. A pilot study of the safety and efficacy of picolinic acid gel in the treatment of acne vulgaris.
Heffernan MP; Nelson MM; Anadkat MJ
Br J Dermatol; 2007 Mar; 156(3):548-52. PubMed ID: 17300246
[TBL] [Abstract][Full Text] [Related]
25. Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
Tanghetti E; Abramovits W; Solomon B; Loven K; Shalita A
J Drugs Dermatol; 2006 Mar; 5(3):256-61. PubMed ID: 16573259
[TBL] [Abstract][Full Text] [Related]
26. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety.
Lain E; Day D; Harper J; Guenin E
J Drugs Dermatol; 2019 Nov; 18(11):1128-1138. PubMed ID: 31741356
[TBL] [Abstract][Full Text] [Related]
27. Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris.
Piette WW; Taylor S; Pariser D; Jarratt M; Sheth P; Wilson D
Arch Dermatol; 2008 Dec; 144(12):1564-70. PubMed ID: 19075138
[TBL] [Abstract][Full Text] [Related]
28. Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population.
Cook-Bolden FE; Weinkle SH; Guenin E; Bhatt V
J Drugs Dermatol; 2019 Jan; 18(1):32-38. PubMed ID: 30681791
[TBL] [Abstract][Full Text] [Related]
29. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
[TBL] [Abstract][Full Text] [Related]
30. A pilot study on efficacy treatment of acne vulgaris using a new method: results of a randomized double-blind trial with Acne Dressing.
Chao CM; Lai WY; Wu BY; Chang HC; Huang WS; Chen YF
J Cosmet Sci; 2006; 57(2):95-105. PubMed ID: 16688374
[TBL] [Abstract][Full Text] [Related]
31. Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: a randomized control trial.
NilFroushzadeh MA; Siadat AH; Baradaran EH; Moradi S
Indian J Dermatol Venereol Leprol; 2009; 75(3):279-82. PubMed ID: 19439881
[TBL] [Abstract][Full Text] [Related]
32. A randomized, controlled, split-face clinical trial of 1320-nm Nd:YAG laser therapy in the treatment of acne vulgaris.
Orringer JS; Kang S; Maier L; Johnson TM; Sachs DL; Karimipour DJ; Helfrich YR; Hamilton T; Voorhees JJ
J Am Acad Dermatol; 2007 Mar; 56(3):432-8. PubMed ID: 17239987
[TBL] [Abstract][Full Text] [Related]
33. Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population.
Kircik LH; Baldwin H; Lain E; Guenin E; Harris S; Bhatt V
J Drugs Dermatol; 2019 Feb; 18(2):178-188. PubMed ID: 30811141
[TBL] [Abstract][Full Text] [Related]
34. Investigation of the mechanism of action of 2% fusidic acid lotion in the treatment of acne vulgaris.
Sommer S; Bojar R; Cunliffe WJ; Holland D; Holland KT; Naags H
Clin Exp Dermatol; 1997 Sep; 22(5):211-5. PubMed ID: 9536540
[TBL] [Abstract][Full Text] [Related]
35. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris.
Tanghetti EA; Kircik LH; Green LJ; Guenin E; Harris S; Martin G; Pillai R
J Drugs Dermatol; 2019 Jun; 18(6):542. PubMed ID: 31251546
[TBL] [Abstract][Full Text] [Related]
36. A comparative split-face study of photodynamic therapy with indocyanine green and indole-3-acetic acid for the treatment of acne vulgaris.
Jang MS; Doh KS; Kang JS; Jeon YS; Suh KS; Kim ST
Br J Dermatol; 2011 Nov; 165(5):1095-100. PubMed ID: 21692772
[TBL] [Abstract][Full Text] [Related]
37. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris.
Shalita AR; Myers JA; Krochmal L; Yaroshinsky A;
J Drugs Dermatol; 2005; 4(1):48-56. PubMed ID: 15696985
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris.
Kircik LH; Dahl A; Yatskayer M; Raab S; Oresajo C
J Drugs Dermatol; 2012 Jun; 11(6):737-40. PubMed ID: 22648221
[TBL] [Abstract][Full Text] [Related]
39. [Clinical evaluation of a topical ethyl lactate treatment of acne vulgaris (author's transl)].
Grosshans E; Fourtanier A; Guibaud B
Ann Dermatol Venereol; 1978 Oct; 105(10):833-8. PubMed ID: 154872
[TBL] [Abstract][Full Text] [Related]
40. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population.
Han G; Armstrong AW; Desai SR; Guenin E
J Drugs Dermatol; 2019 Sep; 18(9):910-916. PubMed ID: 31524347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]